Status:
UNKNOWN
Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze
Lead Sponsor:
L.V. Prasad Eye Institute
Conditions:
Corneal Scars and Opacities
Eligibility:
All Genders
20-40 years
Phase:
PHASE1
Brief Summary
This is a investigator-initiated pilot clinical trial to ascertain the safety and efficacy of application of ex-vivo cultivated limbal stem cells in human eyes for treating Corneal Haze after Photo-Th...
Detailed Description
In this pilot clinical trial, patients undergoing Photo Therapeutic/Refractive Keratectomy (PTK/ PRK) and Collagen Cross Linking (CXL), will be given human Limbus-derived Corneal Stem cells to assess ...
Eligibility Criteria
Inclusion
- Adult patients between20 to 40 years of age
- Meeting standard selection criteria for bilateral PTK/PRK or CXL
- No systemic diseases
- Eligible to give informed consent
- No other ocular co-existing pathologies
Exclusion
- Undergoing surgery in only one eye
- Grossly asymmetric pathology
- Refusal to give informed consent
- Not agreeable or uncooperative for corneal imaging
- Unlikely to come for follow-up for 1 month
- International and out-station patients
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03295292
Start Date
August 1 2017
End Date
June 1 2020
Last Update
February 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LV Prasad Eye Institute
Hyderabad, Telangana, India, 500034